We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Policy

Cannabis Policy

Missouri Launches Its Legal Recreational Cannabis Market Early

Adult-use, recreational cannabis became legally available in Missouri on Friday, February 3 – three days earlier than planned.

Read More

Vermont Regulator Stops the Sale of Contaminated Cannabis Flower

The CCB “has verified” that multiple samples of Holland Cannabis flower tested above the action limits for myclobutanil, a chemical used as a fungicide.

Read More

Australia to Permit MDMA and Psilocybin Prescriptions

From July 1, psychiatrists in Australia will be allowed to prescribe MDMA and psilocybin as treatments for certain mental health conditions.

Read More

The Degradation Pathways of Cannabinoids and How to Manage Them – Part 2

In the second of two articles, scientists from Broughton, a regulatory consultancy currently focused on EU and UK cannabis regulation, discuss the susceptibility of cannabinoids to degrade and summarize the main degradation pathways of THC and CBD.

Read More

UK’s Health Service Can Now Prescribe Epidiolex For Tuberous Sclerosis Complex

The change comes after the National Institute for Health and Care Excellence (NICE) issued final guidance recommending its use.

Read More

Cannabis in the UK: Problems and Solutions

The legal status of cannabis in the UK is in a state of flux, becoming more relaxed in various ways, but too slowly for some. John Binns, a cannabis specialist at BCL Solicitors LLP, gets into the weeds.

Read More

Colorado Regulator Issues Warning About Moldy Flower

State regulators in Colorado have issued another health and safety notice after “potentially unsafe levels” of total yeast and mold and Aspergillus were found in a batch of cannabis flower.

Read More

Oregon Regulator Recalls 1,000 Cannabis Vapes

The products had tested positive for two pesticides, piperonyl butoxide and a pyrethrin.

Read More

FDA Defers to Congress For CBD Food and Supplement Regulations

The federal agency made its decision following a “careful review” of the potential regulatory pathways of CBD products in the US.

Read More

 
Advertisement